5 completed. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 5 |
Follow tonabersat: new trials by email Literature Review of tonabersat trials Research Report on tonabersat
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Xiflamâ„¢ Treatment in Patients Post COVID-19 Infection Suffering From What is Known as Long COVID (LC) Tonabersat, Placebo - Long COVID | Phase 2 | Completed | Inflammx Therapeutics Inc | 16 | 2024-03-12 | 2026-03-06 |
| Evaluation of Tonabersat for DME Tonabersat, Placebo - Diabetic Macular Edema | Phase 2 | Completed | Jaeb Center for Health Research | 129 | 2023-05-02 | 2026-11-20 |
| Dose Ranging Study of the Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache Tonabersat, Placebo - Migraine Without Aura, Migraine With Aura | Phase 2 | Completed | Minster Research Ltd | 542 | 2007-10-01 | 2009-03-31 |
| Tonabersat in the Prophylaxis of Migraine With Aura Tonabersat, Placebo - Migraine With Aura | Phase 2 | Completed | Minster Research Ltd | 39 | 2006-05-01 | 2009-08-31 |
| Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache Tonabersat, Placebo - Migraine Without Aura, Migraine With Aura | Phase 2 | Completed | Minster Research Ltd | 124 | 2006-04-01 | 2009-08-31 |
Migraine with Aura (3) · Migraine without Aura (2) · Post-Acute COVID-19 Syndrome (1)
Minster Research Ltd (3) · Inflammx Therapeutics Inc (1) · Jaeb Center for Health Research (1)
Denmark (2) · United States (2) · Hungary (1) · South Africa (1) · United Kingdom (1)
Jes Olesen, MD (1) · Peter Chang, MD (1) · Peter Goadsby, MD (1) · Richard Lipton, MD (1)
UG1EY014231 (1)